| ||||||||||||||
|
|
|||||||||||||
Department of Anaesthesiology and Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Address correspondence to Chandra Kant Pandey, MD, Department of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India. Address e-mail to ckpandey{at}sgpgi.ac.in
IV lidocaine is effective in suppressing the cough reflex of tracheal intubation, extubation, bronchography, bronchoscopy, and laryngoscopy. We investigated this effect of lidocaine on fentanyl-induced cough in 502 patients of ASA physical status I and II scheduled for elective surgery. The patients were assigned to 2 equal groups to receive either lidocaine 1.5 mg/kg or placebo (0.9% saline) over 5 s 1 min before the administration of fentanyl 3 µg/kg in a randomized and double-blind fashion. Coughs were classified as coughing and graded as mild (12), moderate (34), or severe (5 or more). The results of the study suggest that IV lidocaine 1.5 mg/kg, when administered 1 min before fentanyl, is significantly effective in suppressing fentanyl-induced cough compared to placebo (0.9% saline) (218 versus 165 patients) (P < 0.002) but without affecting the severity of cough (P > 0.05).
IMPLICATIONS: Fentanyl administration elicits cough. IV lidocaine 1.5 mg/kg suppresses fentanyl-induced coughing.
This article has been cited by other articles:
![]() |
T. Oshima, Y. Kasuya, Y. Okumura, T. Murakami, and S. Dohi Identification of independent risk factors for fentanyl-induced cough: [L'identification de facteurs de risque independants pour la toux induite par le fentanyl]. Can J Anesth, August 1, 2006; 53(8): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Pandey, M. Raza, R. Ranjan, V. Singhal, M. Kumar, A. Lakra, D. V. Navkar, A. Agarwal, R. B. Singh, U. Singh, et al. Intravenous lidocaine 0.5 mg{middle dot}kg-1 effectively suppresses fentanyl-induced cough: [L'administration iv de 0,5 mg{middle dot}kg-1 de lidocaine supprime efficacement la toux induite par le fentanyl] Can J Anesth, February 1, 2005; 52(2): 172 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, January 1, 2005; 330(7481): 52 - 52. [Full Text] [PDF] |
||||
|